In addition to therapeutic agents, immune modulating cytokine IFN-γ has been shown to induce TRAIL expression in various tissue NK cells and IFN-γ-activated TRAIL plays a significant role in IFN-γ-dependent tumor suppression [28]. This evidence concerns the gene IFNG and neoplasm.